Montag & Associates’s Affimed AFMD Stock Holding History

Montag & Associates’s Portfolio AFMD Stock Details AFMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,000	Closed	-$6.25K	–	969
2023 Q4	$6.25K	Buy	+1,000	New	+$4.15K	﹤0.01%	811

Other funds holding AFMD

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

GPSPJS

General Pension Society PZU Joint Stock Warsaw, Poland $654M AUM 55.85% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Montag & Associates's AFMD Position: Q1 2024 in Review

Montag & Associates sold out of Affimed (AFMD) in Q1 2024, closing a stake of 1,000 shares — an estimated $6.25K sold.

Montag & Associates first reported a position in AFMD in Q4 2023 and held it in 1 quarter. The position peaked at $6.25K in Q4 2023. 46 funds tracked by Wall St. Rank hold AFMD as of Q1 2024.

Montag & Associates reported no remaining Affimed position as of Q1 2024 after selling out during the quarter.
Montag & Associates sold 1,000 Affimed shares in Q1 2024, an estimated $6.25K.
Montag & Associates first reported a position in Affimed in Q4 2023 and held it in 1 quarter.
Montag & Associates's Affimed position peaked at $6.25K in Q4 2023.
46 funds tracked by Wall St. Rank held Affimed as of Q1 2024.

Based on Montag & Associates's 13F filing for Q1 2024, filed 7 May 2024.